Industries > Pharma > Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

Forecasts by Product (Formulation, Devices), Formulation (Suspension Aerosol, Solution Aerosol, Dry Powder Formulation), Devices (MDIs, DPIs, Nebulizers, Accessories), Nebulizers (Soft Mist Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers), Canister Type (Plain Canisters, Coated Canister), Application (Asthma, COPD, Cystic Fibrosis, Other Applications), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-Commerce), End-user (Hospitals & Clinics, Homecare Settings), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) PLUS Profiles of Leading Respiratory Drug Delivery Companies PLUS COVID-19 Recovery Scenarios

PUBLISHED: 30 September 2020
PAGES: 487
PRODUCT CODE: PHA0927
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0927 Categories: , Tag:

The targeted delivery of antivirals to where the viral load from COVID-19 is heaviest, the respiratory tract, is at the centre of some COVID-19 work. The race for a COVID-19 solution is not just a race for profit or market share, but a race to save increased death, and rescue the global economy.

But it is not just COVID-19 that steers the future of Pulmonary and respiratory drug delivery. This unique senior report tells you what direction the market will take – and it tells you today.

Discover how to stay ahead
• Our 500+ page report provides 500+ tables and charts/graphs.
• Discover the most lucrative areas in your industry and the future market prospects.
• Forecasted sales at overall world market, regional level and specific country breakdown.
• Dedicated financial results, trends, opportunities, and revenue predictions.
• Great opportunities still remain throughout the Pulmonary/Respiratory Drug Delivery Market. See how to exploit the opportunities.

UNIQUE COVID-19 VARIATIONS– only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 affects the economy.

To access the data contained in this document please email contactus@visiongain.com

Which Factors are Fueling Respiratory Drug Delivery Industry Growth?
• Technological Advancements
• Increase in Prevalence and Incidence of Respiratory Diseases
• Respiratory Disease Healthcare Awareness

Which Factors are Restraining Growth?
• Stringent Government Regulations
• Intense Competition Among Players

What are Market Trends?
• Introduction of Smart/Digital Inhalers
• Recent Advances in Pulmonary Drug Delivery
• Trends in MDI Technology
• Trends in DPI Technology
• Pulmonary Drug Delivery will continue to Evolve
• Pulmonary Drug Delivery Can Minimize Systemic Side Effects
• Future of Inhalable Therapeutics
• Alternative Solution to provide Competitive Edge

How do prominent players strengthen their position throughout the world?
You must read this newly updated report if you are involved in this sector. The report from Visiongain gives you key potential revenues up to 2030, evaluates critical development information, trends, opportunities and business outlooks.

Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, Porter’s Analysis, product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Product
• Formulation
• Devices

Formulation
• Suspension Aerosol
• Solution Aerosol
• Dry Powder Formulation

Devices
• MDIs
• DPIs
• Nebulizers
• Accessories

Nebulizers
• Soft Mist Nebulizers
• Jet Nebulizers
• Ultrasonic Nebulizers

Canister Type
• Plain Canisters
• Coated Canister

Application
• Asthma
• COPD
• Cystic Fibrosis
• Other Applications

Distribution Channel
• Retail Pharmacies
• Hospital Pharmacies
• E-Commerce

End-User
• Hospitals & Clinics
• Homecare Settings

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 18 leading national markets:

By Region (Segmental Breakdown for All the Regions)

• North America:
• U.S.
• Canada

• Europe:
• Germany
• France
• UK
• Italy
• Spain
• Belgium
• Switzerland
• Rest of Europe

• Asia Pacific:
• China
• Japan
• India
• Malaysia
• Rest of Asia Pacific

• Latin America:
• Brazil
• Mexico
• Argentina
• Rest of Latin America

• Middle East & Africa:
• GCC
• South Africa
• Rest of Middle East & Africa

Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

Need industry data? Please contact us today.

Leading companies and the potential for market growth
Overall world revenue for Pulmonary/Respiratory Drug Delivery Market will surpass $xx billion in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

Prospects for established firms and those seeking to enter the market– including company profiles for 17 of the major companies involved in the Respiratory Drug Delivery Market. Some of the companies profiled in this report include GlaxoSmithKline plc, Respironics, Inc., Boehringer Ingelheim, 3M, AstraZeneca, Merck & Co., Inc., Novartis AG, OMRON Corporation, Sunovion Pharmaceuticals Inc., Teva Pharmaceutical, F. Hoffmann-La Roche Ltd., Cipla, Pulmatrix, Respiratorius AB, Regeneron Pharmaceuticals, Inc., Grifols, S.A., and Innoviva

Key Questions Answered by this Report:
• What is the current size of the overall global pulmonary/respiratory drug delivery market? How much will this market be worth from 2020 to 2030?
• What are the main drivers and restraints that will shape the overall respiratory drug delivery market over the next ten years?
• What are the main segments within the overall pulmonary/respiratory drug delivery market? How much will each of these segments be worth for the period 2020 to 2030? How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world pulmonary/respiratory drug delivery? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2030?
• How will market shares of the leading national markets change by 2030, and which geographical region will lead the market in 2030?
• Which are the leading companies and what are their activities, results, developments, and prospects?
• What are the main trends that will affect the world pulmonary/respiratory drug delivery market between 2020 and 2030?
• What are the main strengths, weaknesses, opportunities, and threats for the market?
• How will the global pulmonary/respiratory drug delivery market evolve over the forecasted period, 2020 to 2030?
• How will market shares of prominent national markets change from 2020, and which countries will lead the market in 2030, achieving highest revenues and fastest growth?

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is intended for everybody needing commercial analyses for the Global Pulmonary/Respiratory Drug Delivery Market and leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Pulmonary/Respiratory Drug Delivery Market Report 2020-2030: Forecasts by Product (Formulation, Devices), Formulation (Suspension Aerosol, Solution Aerosol, Dry Powder Formulation), Devices (MDIs, DPIs, Nebulizers, Accessories), Nebulizers (Soft Mist Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers), Canister Type (Plain Canisters, Coated Canister), Application (Asthma, COPD, Cystic Fibrosis, Other Applications), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, E-Commerce), End-user (Hospitals & Clinics, Homecare Settings), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) PLUS Profiles of Leading Respiratory Drug Delivery Companies. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pulmonary/Respiratory Drug Delivery Market Report 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Pulmonary/Respiratory Drug Delivery Market Report 2020-2030


Latest Pharma news

Visiongain Publishes Biobanking Market Report 2021-2031

In clinical trials relating to COVID-19, COVID-19 biobanks will play an important role. These biobanks will play an instrumental role in future scientific studies on the emerging coronavirus (COVID-19) pandemic facing the world.

23 October 2020

READ

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

READ

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

READ

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

READ

Categories

Category